222 related articles for article (PubMed ID: 33439112)
1. Rhabdomyosarcoma: From Obscurity to Clarity in Diagnosis … But With Ongoing Challenges in Management: The Farber-Landing Lecture of 2020.
Parham DM; Giannikopoulos P
Pediatr Dev Pathol; 2021; 24(2):87-95. PubMed ID: 33439112
[TBL] [Abstract][Full Text] [Related]
2. Sclerosing rhabdomyosarcoma in adults: report of four cases of a hyalinizing, matrix-rich variant of rhabdomyosarcoma that may be confused with osteosarcoma, chondrosarcoma, or angiosarcoma.
Folpe AL; McKenney JK; Bridge JA; Weiss SW
Am J Surg Pathol; 2002 Sep; 26(9):1175-83. PubMed ID: 12218574
[TBL] [Abstract][Full Text] [Related]
3. Rhabdomyosarcoma: Updates on classification and the necessity of molecular testing beyond immunohistochemistry.
Dehner CA; Rudzinski ER; Davis JL
Hum Pathol; 2024 May; 147():72-81. PubMed ID: 38135061
[TBL] [Abstract][Full Text] [Related]
4. Evolving classification of rhabdomyosarcoma.
Agaram NP
Histopathology; 2022 Jan; 80(1):98-108. PubMed ID: 34958505
[TBL] [Abstract][Full Text] [Related]
5. [Alveolar rhabdomyosarcoma: Two fusion-negative cases lacking PAX3-FOXO1 and PAX7-FOXO1].
Mestre-Alagarda C; Gómez-Mateo MC; Berenguer-Romero MD; Syonghyun NC; Nieto G; Navarro-Fos S
Rev Esp Patol; 2022; 55(1):57-62. PubMed ID: 34980443
[TBL] [Abstract][Full Text] [Related]
6. Soft Tissue Special Issue: Skeletal Muscle Tumors: A Clinicopathological Review.
Kohashi K; Kinoshita I; Oda Y
Head Neck Pathol; 2020 Mar; 14(1):12-20. PubMed ID: 31950473
[TBL] [Abstract][Full Text] [Related]
7. Molecular testing of rhabdomyosarcoma in clinical trials to improve risk stratification and outcome: A consensus view from European paediatric Soft tissue sarcoma Study Group, Children's Oncology Group and Cooperative Weichteilsarkom-Studiengruppe.
Hettmer S; Linardic CM; Kelsey A; Rudzinski ER; Vokuhl C; Selfe J; Ruhen O; Shern JF; Khan J; Kovach AR; Lupo PJ; Gatz SA; Schäfer BW; Volchenboum S; Minard-Colin V; Koscielniak E; Hawkins DS; Bisogno G; Sparber-Sauer M; Venkatramani R; Merks JHM; Shipley J
Eur J Cancer; 2022 Sep; 172():367-386. PubMed ID: 35839732
[TBL] [Abstract][Full Text] [Related]
8. Progress in the diagnosis and treatment of rhabdomyosarcoma and related soft tissue sarcomas.
Ruymann FB; Grovas AC
Cancer Invest; 2000; 18(3):223-41. PubMed ID: 10754991
[TBL] [Abstract][Full Text] [Related]
9. PAX7 Expression in Rhabdomyosarcoma, Related Soft Tissue Tumors, and Small Round Blue Cell Neoplasms.
Charville GW; Varma S; Forgó E; Dumont SN; Zambrano E; Trent JC; Lazar AJ; van de Rijn M
Am J Surg Pathol; 2016 Oct; 40(10):1305-15. PubMed ID: 27526298
[TBL] [Abstract][Full Text] [Related]
10. Sclerosing rhabdomyosarcomas in children and adolescents: a clinicopathologic review of 13 cases from the Intergroup Rhabdomyosarcoma Study Group and Children's Oncology Group.
Chiles MC; Parham DM; Qualman SJ; Teot LA; Bridge JA; Ullrich F; Barr FG; Meyer WH;
Pediatr Dev Pathol; 2004; 7(6):583-94. PubMed ID: 15630526
[TBL] [Abstract][Full Text] [Related]
11. An Integrative Morphologic and Molecular Approach for Diagnosis and Subclassification of Rhabdomyosarcoma.
Fan R; Parham DM; Wang LL
Arch Pathol Lab Med; 2022 Aug; 146(8):953-959. PubMed ID: 35051261
[TBL] [Abstract][Full Text] [Related]
12. Update on Myogenic Sarcomas.
Agaram NP
Surg Pathol Clin; 2019 Mar; 12(1):51-62. PubMed ID: 30709448
[TBL] [Abstract][Full Text] [Related]
13. Sclerosing rhabdomyosarcoma in childhood: case report and review of the literature.
Vadgama B; Sebire NJ; Malone M; Ramsay AD
Pediatr Dev Pathol; 2004; 7(4):391-6. PubMed ID: 15383934
[TBL] [Abstract][Full Text] [Related]
14. Diagnostic utility of FOXO1 immunohistochemistry for rhabdomyosarcoma classification.
Rutland CD; Gedallovich J; Wang A; Zdravkovic S; Varma S; Hornick JL; Charville GW
Histopathology; 2023 Jul; 83(1):49-56. PubMed ID: 36860202
[TBL] [Abstract][Full Text] [Related]
15. [Sclerosing rhabdomyosarcoma: a clinicopathologic study of four cases with review of literature].
Zhu L; Wang J
Zhonghua Bing Li Xue Za Zhi; 2007 Sep; 36(9):587-91. PubMed ID: 18070445
[TBL] [Abstract][Full Text] [Related]
16. Pathologic classification of rhabdomyosarcomas and correlations with molecular studies.
Parham DM
Mod Pathol; 2001 May; 14(5):506-14. PubMed ID: 11353062
[TBL] [Abstract][Full Text] [Related]
17. Diagnosis and Management of Rhabdomyosarcoma in Children and Adolescents: ICMR Consensus Document.
Panda SP; Chinnaswamy G; Vora T; Prasad M; Bansal D; Kapoor G; Radhakrishnan V; Agarwala S; Laskar S; Arora B; Kaur T; Rath GK; Bakhshi S
Indian J Pediatr; 2017 May; 84(5):393-402. PubMed ID: 28378141
[TBL] [Abstract][Full Text] [Related]
18. Clinicopathologic features of 300 rhabdomyosarcomas with emphasis upon differential expression of skeletal muscle specific markers in the various subtypes: A single institutional experience.
Rekhi B; Gupta C; Chinnaswamy G; Qureshi S; Vora T; Khanna N; Laskar S
Ann Diagn Pathol; 2018 Oct; 36():50-60. PubMed ID: 30098515
[TBL] [Abstract][Full Text] [Related]
19. The current landscape of rhabdomyosarcomas: an update.
Leiner J; Le Loarer F
Virchows Arch; 2020 Jan; 476(1):97-108. PubMed ID: 31696361
[TBL] [Abstract][Full Text] [Related]
20. Impact of fusion gene status versus histology on risk-stratification for rhabdomyosarcoma: Retrospective analyses of patients on UK trials.
Selfe J; Olmos D; Al-Saadi R; Thway K; Chisholm J; Kelsey A; Shipley J
Pediatr Blood Cancer; 2017 Jul; 64(7):. PubMed ID: 28035744
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]